Connie W H Woo
Overview
Explore the profile of Connie W H Woo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang C, Wijerathne C, Tu G, Woo C, Siow Y, Madduma Hewage S, et al.
Front Immunol
. 2021 Jun;
12:678914.
PMID: 34149715
Acute or chronic kidney disease can cause micronutrient deficiency. Patients with end-stage renal disease, kidney transplantation or on dialysis have reduced circulating levels of folate, an essential B vitamin. However,...
2.
Cheung Y, O K, Woo C, Armstrong S, Siow Y, Chow P, et al.
BMC Pediatr
. 2008 May;
8:20.
PMID: 18466622
Background: Persistent arterial dysfunction in patients with a history of Kawasaki disease (KD) and an integral role of oxidative stress in the development of cardiovascular disease are increasingly recognized. We...
3.
Edirimanne V, Woo C, Siow Y, Pierce G, Xie J, O K
Can J Physiol Pharmacol
. 2007 Dec;
85(12):1236-47.
PMID: 18066125
Elevation of blood homocysteine (Hcy) levels (hyperhomocysteinemia) is a risk factor for cardiovascular disorders. We previously reported that oxidative stress contributed to Hcy-induced inflammatory response in vascular cells. In this...
4.
Woo C, Siow Y, O K
J Biol Chem
. 2007 Nov;
283(3):1282-1292.
PMID: 18024959
Hyperhomocysteinemia is characterized by abnormally high concentrations of homocysteine (Hcy) in the plasma. It is a metabolic disorder associated with dysfunction of several organs such as atherosclerosis, altered lipid metabolism,...
5.
Hwang S, Woo C, Au-Yeung K, Siow Y, Zhu T, O K
Am J Physiol Renal Physiol
. 2007 Nov;
294(1):F236-44.
PMID: 17977907
Hyperhomocysteinemia, or an elevation of blood homocysteine (Hcy) levels, is associated with cardiovascular disorders. Although kidney dysfunction is an important risk factor causing hyperhomocysteinemia, the direct effect of Hcy on...
6.
Woo C, Prathapasinghe G, Siow Y, O K
Biochim Biophys Acta
. 2006 Jul;
1762(7):656-65.
PMID: 16837172
Hyperhomocysteinemia, a condition of elevated blood homocysteine level, is an independent risk factor for cardiovascular diseases. Hyperhomocysteinemia is also found in patients with liver diseases. However, the direct effect of...
7.
Siow Y, Au-Yeung K, Woo C, O K
Biochem J
. 2006 Apr;
398(1):73-82.
PMID: 16626305
Hyperhomocysteinaemia is an independent risk factor for cardiovascular diseases due to atherosclerosis. The development of atherosclerosis involves reactive oxygen species-induced oxidative stress in vascular cells. Our previous study [Wang and...
8.
Woo C, Siow Y, O K
Arterioscler Thromb Vasc Biol
. 2006 Feb;
26(5):1043-50.
PMID: 16497994
Objective: Hyperhomocysteinemia is an independent risk factor for cardiovascular disorders. Our previous studies demonstrated that hyperhomocysteinemia not only elicited inflammatory responses in the vascular endothelium but also induced fatty liver...
9.
Woo C, Man R, Siow Y, Choy P, Wan E, Lau C, et al.
Mol Cell Biochem
. 2005 Dec;
275(1-2):165-71.
PMID: 16335796
Nitric oxide (NO) is a principal mediator in many physiological and pathological processes. Overproduction of NO via the inducible nitric oxide synthase (iNOS) has cytotoxic effect through the formation of...
10.
Siow Y, Gong Y, Au-Yeung K, Woo C, Choy P, O K
Can J Physiol Pharmacol
. 2005 May;
83(4):321-34.
PMID: 15877107
Traditional Chinese medicine (TCM) has many beneficial effects and has been practiced for several thousand years. It is known to treat the cause of a disease rather than to alleviate...